In 1997, we established the first Fertility Center in ShenZhen.
In 1998, the first IVF baby in our center was born, which also is the first case in ShenZhen.
In 1999, the first ICSI baby in our center was born, which also is the first case in ShenZhen.
In 2000, the first mixed blood tube baby in our center was born, which also is the first case in ShenZhen.
In 2003, the first pronuclear transfer tube baby in our center was born.
In 2005, FNA-Mapping sperm extraction was carried out.
In 2006, we start using mini-stimulation protocol.
In 2006, we manage to apply reproductive immunological therapy, aiming at improve the success rate of assisted reproductive technology(ART).
In 2009, with the support of the municipal government, our hospital moved to No. 1001, Fuqiang Road, Futian District.
In 2010, our reproductive immunology department was established.
In 2010, mature application of vitrification freezing technology came true.
In 2011, our Urology and Reproductive Laboratory was approved as "Shenzhen Medical Key Discipline (Key Laboratory)" by the Municipal Health Commission, and our hospital was approved as "Postdoctoral Innovation Practice Base" by the Shenzhen Human Security Bureau.
In 2012, our Reproductive Medicine Center was approved by Shenzhen Science and Technology Commission to establish "Shenzhen Key Laboratory for Reproductive Immunology of Peri-implantation".
In 2014, we established the immune cell profile of endometrial receptivity.
In 2014, we held the first Conference on New Trends in Clinical and Basic Research on Reproductive Immunology.
In 2015, our "Immune Status Evaluation System for Recurrent Miscarriage of Unexplained Reasons" won the first prize of Shenzhen Municipal Science and Technology Progress Award.
In 2016, we were approved to establish the "Sanming Project" of Shenzhen Medical and Health.
In 2016, we obtained 1 National Natural Science Foundation of China (NSFC) and subject layout guide of Shenzhen basic research respectively, and 4 provincial and municipal projects, and published five SCI papers.
In 2016 to 2017, two patents related to endometrial receptivity were approved.
In 2018, we established the reproductive traditional Chinese medicine(TCM) Department.
In 2018, our hospital was honored the "class AAAAA honest private hospital".
In 2018, we held the American-Sino Joint Meeting of Reproductive Immunology--The 38th annual meeting of the American Society for Reproductive Immunology with Fudan University jointly .
In 2018, we established the Reproductive Miscarriage-Preventing department.
In 2018, the reproductive immunology team was awarded the third prize of Chinese medical science and Technology Award and the second prize of Chinese medical science and technology award.
In 2018, our hospital was approved as Guangdong engineering technology research and Development Center.
In 2018, we established the Department of genitourinary andrology.
In 2018, a utility model patent was approved.
In 2019, with the support of municipal government government, our hospital successfully organized a public benefit activities which aims at helping 100 infertile couples in Futian district in the recent 5 years.
In 2019, six projects were approved, including two provincial natural science funds.
In 2019, 4 invention patents and 4 utility model patents were approved.
In 2019, 19 papers were published, including 11 Chinese core journals and 8 SCI papers.
In November 2019, we successfully held the 5th Conference on New Trends in Clinical and Basic Research on Reproductive Immunology.
Copyright©1987-2020 ShenZhen ZhongShan Urology Hospital